Curaleaf, the largest cannabis company in the U.S., is on its way to become the largest of its kind in the world after announcing a $286 million deal to acquire European marijuana company Emmac Life Sciences.
The Massachusetts-based cultivator and retailer announced Tuesday that it has agreed to acquire Emmac for a combination of cash and stock. The deal, which is expected to close during the second quarter of this year, will expand Curaleaf’s footprint to eight countries, including Germany, Italy, Portugal, Spain, and the United Kingdom.